宫腔镜下输卵管插管通液术 中国就医指南

Hysteroscopic tubal cannulation and flushing is a minimally invasive, outpatient surgical procedure performed within the reproductive medicine specialty to diagnose and treat proximal tubal occlusion—a common cause of female infertility. It involves the insertion of a hysteroscope through the cervix into the uterine cavity, followed by precise catheter-guided cannulation of the fallopian tube ostia (cornual openings) under direct visualization. A saline or contrast medium is then gently flushed to assess tubal patency and potentially dislodge mucus plugs, fibrin debris, or mild adhesions obstructing the intramural or isthmic segments. Unlike laparoscopic surgery or IVF, this technique targets mechanical blockages at the uterotubal junction without requiring abdominal incisions or general anesthesia in most cases. Pathophysiologically, proximal tubal occlusion often arises from chronic endometritis, post-infectious scarring (e.g., following chlamydia or gonorrhea), iatrogenic trauma (e.g., after abortion or curettage), or silent intrauterine inflammation leading to cornual stenosis or functional spasm. Epidemiologically, proximal tubal obstruction accounts for approximately 10–25% of all tubal factor infertility cases, with prevalence estimates ranging from 8% to 15% among women undergoing fertility evaluation in tertiary reproductive centers across China and other high-income countries. Risk factors include prior pelvic inflammatory disease (PID), history of uterine instrumentation (e.g., D&C, IUD insertion/removal), recurrent miscarriage, endometrial tuberculosis (especially in endemic regions), and chronic endometrial immune dysregulation. Importantly, many affected women are asymptomatic—lacking classic signs like pelvic pain or fever—making diagnosis reliant on hysterosalpingography (HSG) or sonohysterography as screening tools. The quality-of-life impact is profound yet often underrecognized: patients frequently experience emotional distress, marital strain, social stigma, diminished self-worth, and financial burden due to prolonged infertility journeys. While not curative for severe tubal damage or distal obstruction, successful cannulation restores natural conception potential in 25–45% of appropriately selected patients within 6–12 months post-procedure—offering a cost-effective, fertility-preserving alternative before advancing to assisted reproductive technologies. Patient selection is critical: ideal candidates demonstrate unilateral or bilateral proximal occlusion on HSG with normal distal anatomy, no hydrosalpinx, and preserved ovarian reserve. Complications are rare (<2%) and include transient cramping, uterine perforation (0.1–0.3%), or tubal spasm mimicking obstruction; however, real-time hysteroscopic guidance significantly improves diagnostic accuracy over HSG alone and reduces false-positive occlusion rates by up to 30%.

# 宫腔镜下输卵管插管通液术治疗与费用指南（生殖医学科）

一、非手术保守方案（适用于轻度粘连、近端梗阻、备孕初期患者）

• •药物治疗：促排卵+抗生素（多西环素+甲硝唑）+中药灌肠，疗程3个月；费用：2,800–4,500元（含激素六项、阴道分泌物培养、盆腔超声）
• •理疗联合监测：短波理疗+宫腔灌注透明质酸钠+周期性输卵管造影随访；费用：3,200–5,600元（含治疗费、3次造影对比影像学评估）

二、手术/微创核心介入方案（适用于HSG证实近端梗阻、既往通液失败、有生育诉求者）

• •宫腔镜下输卵管插管通液术（单侧/双侧）：直视下导丝介入+亚甲蓝通液+局部粘连松解；术前必查：传染病四项、心电图、凝血功能、阴道微生态、子宫内膜容受性检测（ERA可选）；
• •全套费用：8,600–12,800元（含宫腔镜耗材、麻醉费、手术费、病理送检、术后3次复查超声及通液评估）

三、特殊复杂方案（合并中重度盆腔粘连、结核性输卵管炎、术后复发性梗阻）

• •联合腹腔镜+宫腔镜“双镜联合”松解+输卵管吻合/造口；或转IVF-ET助孕；费用：22,000–35,000元（含术中冰冻病理、防粘连屏障材料、术后抗结核/免疫调节治疗）

四、方案快速选择指南

• •预算≤6,000元+轻度异常 → 优选药物+理疗保守方案
• •预算8,000–13,000元+明确近端梗阻 → 首选宫腔镜插管通液术（一线微创介入）
• •反复通液失败/合并盆腔病变/年龄＞35岁 → 直接评估IVF路径，避免延误生育时机